Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients
Clinical trial NCT02646189 · COMPLETED
Trial details
- NCT number
- NCT02646189
- Sponsor
- Replicor Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-08-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.